Relive the excitement of the Patriots’ path to their fourth Super Bowl Championship with “Pumped,” a special commemorative book from The Boston Globe.

Abiomed stock falls 31 percent after the Danvers company says it’s under federal investigation

Shares of Abiomed Inc. plunged by nearly one-third on the Nasdaq stock exchange Thursday after the Danvers company said it is the subject of a federal investigation.

In documents filed with the Securities and Exchange Commission, the cardiac device maker disclosed it has received a subpoena from the US attorney’s office seeking files related to the labeling and marketing of its Impella 2.5 heart pump.

Continue reading below

“We are in the process of responding to the subpoena and intend to cooperate fully,” Abiomed said in the filing.

Abiomed’s shares closed Thursday at $13.61, down $6.21, or 31.33 percent, on the Nasdaq.

Robert Weisman can be reached at weisman@globe.com.
Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com